Forian (Forian) Accounts Receivable : $4.27 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Forian Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Forian's accounts receivables for the quarter that ended in Mar. 2024 was $4.27 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Forian's Days Sales Outstanding for the quarter that ended in Mar. 2024 was 79.86.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Forian's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was $0.63.

Forian Accounts Receivable Historical Data

The historical data trend for Forian's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forian Accounts Receivable Chart

Forian Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Receivable

0.02

1.95

1.81

2.57

Forian Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Receivable	Get a 7-Day Free Trial												3.80	3.84	2.92	2.57	4.27

Forian Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Forian Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Forian's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	4.268	/	4.877	*	91
=	79.86

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Forian's accounts receivable are only considered to be worth 75% of book value:

Forian's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(47.435	+	0.75 * 4.268	+	0.5 * 0	-	30.95
-	0	-	0)	/	31.0932
=	0.63

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Forian Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Forian's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Forian (Forian) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Forian Inc (NAS:FORA) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

41 University Drive, Suite 400, Newtown, PA, USA, 18940

Website

https://www.forian.com

Forian Inc provides a suite of SaaS solutions, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments, as well as cannabis dispensaries, manufacturers, cultivators, and regulators.

Executives

Martin J Wygod	director	P.O. BOX 676306, RANCHO SANTA FE CA 92067
Trotman Stanley S Jr	director
Max C Wygod	director, officer: Executive Chairman	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Max Wygod Family Dynasty Trust	10 percent owner	41 UNIVERSITY DRIVE, SUITE 400, NEWTOWN PA 18940
Michael Vesey	officer: Chief Financial Officer	4041-T HADLEY ROAD, S. PLAINFIELD NJ 07080
Jennifer Hajj	director	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Kristiina Md Vuori	director	C/O WEBMD HEALTH CORP., 111 EIGHTH AVENUE, NEW YORK NY 10011
Scott Matthew Ogur	director	C/O HELIX TCS, INC., 10200 E. GIRARD AVENUE, SUITE B420, DENVER CO 80231
Farren Clifford A Jr	officer: Chief Financial Officer	C/O SYNAVANT INC, 3445 PEACHTREE ROAD NE SUITE 1400, ATLANTA GA 30326
Adler Mark J Md	director
Ian Banwell	director	P.O. BOX 34004, CHARLOTTE NC 28234
Shahir Kassam-adams	director	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Adam H Dublin	director, officer: Chief Strategy Officer	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Daniel J Barton	director, officer: Chief Executive Officer	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Alyssa F Varadhan	director	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940